Newsroom
Inflammatix in the news
Recognizing It Early While Getting It Right: The Value of Novel Sepsis Testing Tools
April 2, 2025
A better, faster sepsis test that can save lives
February 6, 2025
Inflammatix Gets FDA Clearance for 30-Minute Sepsis Test, Preps for US Launch
January 21, 2025
Inflammatix Scores FDA Approval for Precision Infection Test
January 21, 2025
Inflammatix begins trial evaluating mRNA test for patient infection status
November 12, 2024
Inflammatix Adds MedTech Veteran as First General Counsel
October 10, 2024
Inflammatix Raises $57M in Series E Financing
September 12, 2024
Inflammatix collects $57M as it awaits FDA review of infectious disease test
September 12, 2024
Press releases
March 25, 2025
Inflammatix Ships TriVerity™ Test Cartridges and Myrna™ Instruments to the U.S. Military
January 21, 2025
Inflammatix Receives FDA Clearance for First-in-Class TriVerity™ Test
November 11, 2024
Inflammatix Initiates TriVerity™ for Improved Management of Emergency Department Patients with Suspected Infections (TIMED) Trial
October 10, 2024
Inflammatix Adds Three MedTech Industry Veterans to Executive Leadership Team
October 1, 2024
Inflammatix Presents Data at ACEP24 Showing High Diagnostic and Prognostic Accuracy of its TriVerity™ Test Regardless of Patient Immune Status
September 12, 2024
Inflammatix Secures $57 Million to Advance Novel Diagnostic for Patients with Suspected Infections or Sepsis
November 28, 2023
Inflammatix Receives Breakthrough Device Designation from FDA for TriVerity™ Acute Infection and Sepsis Test System
November 15, 2023
Inflammatix Completes Technical Development for TriVerity™ Acute Infection and Sepsis Test System
Machine learning blogs
Lessons learned for generative AI for tabular data
August 29, 2023
By Kirindi Choi, Ljubomir Buturovic, Roland Luethy, Inflammatix, Inc. Introduction Recently, generative artificial intelligence (AI)
Decision threshold optimization for diagnostic tests using a genetic algorithm ML
March 15, 2023
By Roland Luethy and Ljubomir Buturovic, Inflammatix, Inc. Introduction Typically, a clinical classifier generates a
Searching for the Best Tabular Data Classifiers
June 22, 2022
By Nandita Damaraju, Ljubomir Buturovic, Inflammatix, Inc. Are neural networks better than other machine learning
Adaptive CV: An approach for faster cross validation and hyperparameter tuning
February 3, 2022
By Nandita Damaraju, Inflammatix, Inc. Introduction Identification of optimal hyperparameters is an integral component for
Podcasts
Diagnosing Infection with Ljubomir Buturovic from Inflammatix
December 2023
Advances in Sepsis Diagnostics: the HostDx Sepsis Platform
May 2018